Department of Emergency Medicine, St. Mary Mercy Hospital, Livonia, Michigan.
Department of Internal Medicine, St. Mary Mercy Hospital, Livonia, Michigan.
J Emerg Med. 2020 Feb;58(2):183-190. doi: 10.1016/j.jemermed.2020.01.003. Epub 2020 Feb 11.
Incidence of delayed intracranial hemorrhage (DICH) in patients on warfarin has been controversial. No previous literature has reported the utility of international normalized ratio (INR) in predicting traumatic DICH.
Utilizing INR to risk stratify head trauma patients who may be managed without repeat imaging.
This was a retrospective study at a Level II trauma center. All patients on warfarin with head injuries from March 2014 to December 31, 2017 were included. Each patient underwent an initial head computed tomography scan (HCT) and subsequent repeat HCT 12 h after. Patients presenting > 12 h after head injury received only one HCT. Two blinded neuroradiologists reviewed each case of DICH. Statistical analysis evaluated Glasgow Coma Scale (GCS), Injury Severity Score (ISS), heart rate, systolic blood pressure (SBP), age, and platelet count.
There were 395 patients who qualified for the protocol; 238 were female. Average age was 79 years. Seventy-seven percent of patients underwent repeat HCT. Five resulted in DICH (INR 2.6-3.0), three of which might have been present on initial HCT; incidence rate of 0.51-1.27%. One patient required neurosurgical intervention. Among 80 patients with INR < 2, no DICH was identified, resulting in high sensitivity, but with a wide confidence interval; sensitivity of 100% (95% confidence interval [CI] 47.8-100), specificity 21% (95% CI 16.6-28.9). Correlation of factors: ISS (p = 0.039), GCS (p = 0.978), HR (p = 0.601), SBP (p = 0.198), age (p = 0.014), and platelets (p = 0.281).
No patient with INR < 2 suffered DICH, suggesting that warfarin users presenting with INR < 2 may be managed without repeat HCT. For INR > 2, patients age and injury severity can be used for shared decision-making to discharge home with standard head injury precautions and no repeat HCT.
华法林使用者颅内迟发性出血(DICH)的发生率一直存在争议。以前没有文献报道国际标准化比值(INR)在预测外伤性 DICH 中的作用。
利用 INR 对可能无需重复影像学检查的颅脑外伤患者进行风险分层。
这是一项在二级创伤中心进行的回顾性研究。纳入 2014 年 3 月至 2017 年 12 月期间所有接受华法林治疗且头部受伤的患者。每位患者均行初始头部计算机断层扫描(HCT),并在 12 小时后进行重复 HCT。受伤后>12 小时就诊的患者仅接受一次 HCT。两名盲法神经放射科医生对每个 DICH 病例进行了评估。统计学分析评估了格拉斯哥昏迷评分(GCS)、损伤严重程度评分(ISS)、心率、收缩压(SBP)、年龄和血小板计数。
共有 395 名符合方案的患者;其中 238 名女性。平均年龄为 79 岁。77%的患者接受了重复 HCT。其中 5 例发生 DICH(INR 2.6-3.0),其中 3 例可能在初始 HCT 中就已存在;发生率为 0.51-1.27%。1 例患者需要神经外科干预。在 INR<2 的 80 名患者中,未发现 DICH,这导致了高敏感性,但置信区间较宽;敏感性为 100%(95%置信区间 [CI] 47.8-100),特异性为 21%(95% CI 16.6-28.9)。相关因素的相关性:ISS(p=0.039)、GCS(p=0.978)、HR(p=0.601)、SBP(p=0.198)、年龄(p=0.014)和血小板(p=0.281)。
INR<2 的患者均未发生 DICH,提示 INR<2 的华法林使用者无需重复 HCT 即可接受治疗。对于 INR>2 的患者,可根据患者年龄和损伤严重程度进行决策,以标准的颅脑外伤预防措施出院,无需重复 HCT。